Cefixime 200 mg + Clavulanic Acid 125 mg Tablets
CIXUP-CL contains cefixime, an oral third-generation cephalosporin antibiotic, combined with clavulanic acid, a beta-lactamase inhibitor.
Cefixime acts by inhibiting bacterial cell-wall synthesis. Clavulanic acid inhibits certain beta-lactamase enzymes involved in bacterial resistance to beta-lactam antibiotics.
The combination brings together two distinct pharmacological actions. However, the addition of clavulanic acid does not necessarily improve cefixime activity against every resistant bacterial strain.
Treatment with CIXUP-CL should be based on the approved indication, clinical assessment and relevant bacterial susceptibility patterns. Antibiotic use must follow current prescribing guidance.
Composition: Cefixime 200 mg + Clavulanic Acid 125 mg
Dosage Form: Tablets
Packing: 10 x 6 Strip Pack
Prescription medicine. To be used under medical supervision.
Cephalosporin and beta-lactamase inhibitor combination: Contains cefixime 200 mg and clavulanic acid 125 mg.
Bacterial cell-wall inhibition: Cefixime interferes with bacterial cell-wall synthesis.
Beta-lactamase inhibition: Clavulanic acid inhibits certain beta-lactamase enzymes, although this does not establish clinical activity against every resistant organism.
Oral tablet formulation: Provides the two ingredients in a single fixed-dose tablet.
Clinical considerations: Selection should be guided by the authorised indication, bacterial susceptibility and responsible antibiotic prescribing.
Therapeutic Indications — Label Verification Required
CIXUP-CL is an antibacterial fixed-dose combination containing cefixime and clavulanic acid.
Use is restricted to bacterial infections for which the exact combination is authorised and clinically appropriate.
Specific indications must be confirmed from the approved Indian product label before being displayed on the website.
Not indicated for viral infections.
Verified product information, formulation specifications, and commercial supply pathways for registered healthcare professionals, institutions, and trade partners.
Review verified active composition, strength, dosage form, and packaging details on this page.
View SpecificationsRequest formulation literature, technical specifications, or product communication from our commercial team.
Submit Product EnquiryConnect regarding institutional supply requirements, trade distribution, or third-party contract manufacturing.
Commercial EnquiryThis product information is intended for registered healthcare professionals, medical practitioners, and authorized distribution partners. Product manufacturing is coordinated through eligible facility partners under applicable licences.
Request information about CIXUP-CL for professional use.